Cargando…
A bispecific IgG format containing four independent antigen binding sites
Bispecific antibodies come in many different formats, including the particularly interesting two-in-one antibodies, where one conventional IgG binds two different antigens. The IgG format allows these antibodies to mediate Fc-related functionality, and their wild-type structure ensures low immunogen...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994471/ https://www.ncbi.nlm.nih.gov/pubmed/32005942 http://dx.doi.org/10.1038/s41598-020-58150-z |
_version_ | 1783493197165494272 |
---|---|
author | Ljungars, Anne Schiött, Torbjörn Mattson, Ulrika Steppa, Jessica Hambe, Björn Semmrich, Monika Ohlin, Mats Tornberg, Ulla-Carin Mattsson, Mikael |
author_facet | Ljungars, Anne Schiött, Torbjörn Mattson, Ulrika Steppa, Jessica Hambe, Björn Semmrich, Monika Ohlin, Mats Tornberg, Ulla-Carin Mattsson, Mikael |
author_sort | Ljungars, Anne |
collection | PubMed |
description | Bispecific antibodies come in many different formats, including the particularly interesting two-in-one antibodies, where one conventional IgG binds two different antigens. The IgG format allows these antibodies to mediate Fc-related functionality, and their wild-type structure ensures low immunogenicity and enables standard methods to be used for development. It is however difficult, time-consuming and costly to generate two-in-one antibodies. Herein we demonstrate a new approach to create a similar type of antibody by combining two different variable heavy (VH) domains in each Fab arm of an IgG, a tetra-VH IgG format. The VHs are used as building blocks, where one VH is placed at its usual position, and the second VH replaces the variable light (VL) domain in a conventional IgG. VH domains, binding several different types of antigens, were discovered and could be rearranged in any combination, offering a convenient “plug and play” format. The tetra-VH IgGs were found to be functionally tetravalent, binding two antigens on each arm of the IgG molecule simultaneously. This offers a new strategy to also create monospecific, tetravalent IgGs that, depending on antigen architecture and mode-of-action, may have enhanced efficacy compared to traditional bivalent antibodies. |
format | Online Article Text |
id | pubmed-6994471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-69944712020-02-06 A bispecific IgG format containing four independent antigen binding sites Ljungars, Anne Schiött, Torbjörn Mattson, Ulrika Steppa, Jessica Hambe, Björn Semmrich, Monika Ohlin, Mats Tornberg, Ulla-Carin Mattsson, Mikael Sci Rep Article Bispecific antibodies come in many different formats, including the particularly interesting two-in-one antibodies, where one conventional IgG binds two different antigens. The IgG format allows these antibodies to mediate Fc-related functionality, and their wild-type structure ensures low immunogenicity and enables standard methods to be used for development. It is however difficult, time-consuming and costly to generate two-in-one antibodies. Herein we demonstrate a new approach to create a similar type of antibody by combining two different variable heavy (VH) domains in each Fab arm of an IgG, a tetra-VH IgG format. The VHs are used as building blocks, where one VH is placed at its usual position, and the second VH replaces the variable light (VL) domain in a conventional IgG. VH domains, binding several different types of antigens, were discovered and could be rearranged in any combination, offering a convenient “plug and play” format. The tetra-VH IgGs were found to be functionally tetravalent, binding two antigens on each arm of the IgG molecule simultaneously. This offers a new strategy to also create monospecific, tetravalent IgGs that, depending on antigen architecture and mode-of-action, may have enhanced efficacy compared to traditional bivalent antibodies. Nature Publishing Group UK 2020-01-31 /pmc/articles/PMC6994471/ /pubmed/32005942 http://dx.doi.org/10.1038/s41598-020-58150-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ljungars, Anne Schiött, Torbjörn Mattson, Ulrika Steppa, Jessica Hambe, Björn Semmrich, Monika Ohlin, Mats Tornberg, Ulla-Carin Mattsson, Mikael A bispecific IgG format containing four independent antigen binding sites |
title | A bispecific IgG format containing four independent antigen binding sites |
title_full | A bispecific IgG format containing four independent antigen binding sites |
title_fullStr | A bispecific IgG format containing four independent antigen binding sites |
title_full_unstemmed | A bispecific IgG format containing four independent antigen binding sites |
title_short | A bispecific IgG format containing four independent antigen binding sites |
title_sort | bispecific igg format containing four independent antigen binding sites |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994471/ https://www.ncbi.nlm.nih.gov/pubmed/32005942 http://dx.doi.org/10.1038/s41598-020-58150-z |
work_keys_str_mv | AT ljungarsanne abispecificiggformatcontainingfourindependentantigenbindingsites AT schiotttorbjorn abispecificiggformatcontainingfourindependentantigenbindingsites AT mattsonulrika abispecificiggformatcontainingfourindependentantigenbindingsites AT steppajessica abispecificiggformatcontainingfourindependentantigenbindingsites AT hambebjorn abispecificiggformatcontainingfourindependentantigenbindingsites AT semmrichmonika abispecificiggformatcontainingfourindependentantigenbindingsites AT ohlinmats abispecificiggformatcontainingfourindependentantigenbindingsites AT tornbergullacarin abispecificiggformatcontainingfourindependentantigenbindingsites AT mattssonmikael abispecificiggformatcontainingfourindependentantigenbindingsites AT ljungarsanne bispecificiggformatcontainingfourindependentantigenbindingsites AT schiotttorbjorn bispecificiggformatcontainingfourindependentantigenbindingsites AT mattsonulrika bispecificiggformatcontainingfourindependentantigenbindingsites AT steppajessica bispecificiggformatcontainingfourindependentantigenbindingsites AT hambebjorn bispecificiggformatcontainingfourindependentantigenbindingsites AT semmrichmonika bispecificiggformatcontainingfourindependentantigenbindingsites AT ohlinmats bispecificiggformatcontainingfourindependentantigenbindingsites AT tornbergullacarin bispecificiggformatcontainingfourindependentantigenbindingsites AT mattssonmikael bispecificiggformatcontainingfourindependentantigenbindingsites |